Transdermal Patch Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Transdermal Patch Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI14103 | Date : Jan, 2021 | Pages :
180 | Region : Global |
Publisher : RI
The Transdermal Patch market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Transdermal Patch market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
By Application
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
Competitive Landscape and Transdermal Patch Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Transdermal Patch competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Transdermal Patch sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transdermal Patch sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transdermal Patch market presented in the report. This section sheds light on the sales growth of different regional and country-level Transdermal Patch markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transdermal Patch market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Transdermal Patch market for the forecast period 2020 - 2028?
• What are the driving forces in the Transdermal Patch market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Transdermal Patch industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Study Coverage
1.1 Transdermal Patch Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Transdermal Patch Market Size Growth Rate by Product
1.4.2 Fentanyl Transdermal Patch
1.4.3 Nicotine Transdermal Patch
1.4.4 Buprenorphine Transdermal Patch
1.4.5 Clonidine Transdermal Patch
1.4.6 Oxybutynin Transdermal Patch
1.4.7 Others
1.5 Market by End User
1.5.1 Global Transdermal Patch Market Size Growth Rate by End User
1.5.2 Used to Stop Smoking Cigarettes
1.5.3 Used to Treat High Blood Pressure
1.5.4 Used to Relieve Severe Pain
1.5.5 Used to Treat an Overactive Bladder
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size
2.1.1 Global Transdermal Patch Revenue 2015-2028
2.1.2 Global Transdermal Patch Sales 2015-2028
2.2 Transdermal Patch Growth Rate by Regions
2.2.1 Global Transdermal Patch Sales by Regions
2.2.2 Global Transdermal Patch Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Transdermal Patch Sales by Manufacturers
3.1.1 Transdermal Patch Sales by Manufacturers
3.1.2 Transdermal Patch Sales Market Share by Manufacturers
3.1.3 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI)
3.2 Transdermal Patch Revenue by Manufacturers
3.2.1 Transdermal Patch Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Patch Revenue Share by Manufacturers (2015-2020)
3.3 Transdermal Patch Price by Manufacturers
3.4 Transdermal Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Transdermal Patch Sales by Product
4.2 Global Transdermal Patch Revenue by Product
4.3 Transdermal Patch Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Transdermal Patch Breakdown Data by End User
6 North America
6.1 North America Transdermal Patch by Countries
6.1.1 North America Transdermal Patch Sales by Countries
6.1.2 North America Transdermal Patch Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Transdermal Patch by Product
6.3 North America Transdermal Patch by End User
7 Europe
7.1 Europe Transdermal Patch by Countries
7.1.1 Europe Transdermal Patch Sales by Countries
7.1.2 Europe Transdermal Patch Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Patch by Product
7.3 Europe Transdermal Patch by End User
8 Asia Pacific
8.1 Asia Pacific Transdermal Patch by Countries
8.1.1 Asia Pacific Transdermal Patch Sales by Countries
8.1.2 Asia Pacific Transdermal Patch Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Transdermal Patch by Product
8.3 Asia Pacific Transdermal Patch by End User
9 Central & South America
9.1 Central & South America Transdermal Patch by Countries
9.1.1 Central & South America Transdermal Patch Sales by Countries
9.1.2 Central & South America Transdermal Patch Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Transdermal Patch by Product
9.3 Central & South America Transdermal Patch by End User
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Patch by Countries
10.1.1 Middle East and Africa Transdermal Patch Sales by Countries
10.1.2 Middle East and Africa Transdermal Patch Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Transdermal Patch by Product
10.3 Middle East and Africa Transdermal Patch by End User
11 Company Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Transdermal Patch Products Offered
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Transdermal Patch Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Teikoku Pharma
11.4.1 Teikoku Pharma Company Details
11.4.2 Company Business Overview
11.4.3 Teikoku Pharma Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teikoku Pharma Transdermal Patch Products Offered
11.4.5 Teikoku Pharma Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Transdermal Patch Products Offered
11.5.5 Mylan Recent Development
11.6 Actavis
11.6.1 Actavis Company Details
11.6.2 Company Business Overview
11.6.3 Actavis Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Actavis Transdermal Patch Products Offered
11.6.5 Actavis Recent Development
11.7 Mundipharma
11.7.1 Mundipharma Company Details
11.7.2 Company Business Overview
11.7.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mundipharma Transdermal Patch Products Offered
11.7.5 Mundipharma Recent Development
11.8 Henan Lingrui Pharmaceutical
11.8.1 Henan Lingrui Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Henan Lingrui Pharmaceutical Transdermal Patch Products Offered
11.8.5 Henan Lingrui Pharmaceutical Recent Development
11.9 Changzhou Siyao
11.9.1 Changzhou Siyao Company Details
11.9.2 Company Business Overview
11.9.3 Changzhou Siyao Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Changzhou Siyao Transdermal Patch Products Offered
11.9.5 Changzhou Siyao Recent Development
11.10 Rfl Pharmaceutical
11.10.1 Rfl Pharmaceutical Company Details
11.10.2 Company Business Overview
11.10.3 Rfl Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Rfl Pharmaceutical Transdermal Patch Products Offered
11.10.5 Rfl Pharmaceutical Recent Development
12 Future Forecast
12.1 Transdermal Patch Market Forecast by Regions
12.1.1 Global Transdermal Patch Sales Forecast by Regions 2021-2028
12.1.2 Global Transdermal Patch Revenue Forecast by Regions 2021-2028
12.2 Transdermal Patch Market Forecast by Product
12.2.1 Global Transdermal Patch Sales Forecast by Product 2021-2028
12.2.2 Global Transdermal Patch Revenue Forecast by Product 2021-2028
12.3 Transdermal Patch Market Forecast by End User
12.4 North America Transdermal Patch Forecast
12.5 Europe Transdermal Patch Forecast
12.6 Asia Pacific Transdermal Patch Forecast
12.7 Central & South America Transdermal Patch Forecast
12.8 Middle East and Africa Transdermal Patch Forecast
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.